Article Details
Retrieved on: 2021-06-18 21:39:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here